Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)
NCT02837523 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Cystinosis disease from the blood
Conditions
- Renal Fanconi Syndrome
- Photophobia
- Hypophosphatemia
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-08-31
- Completion
- 2021-08-31
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Biomarkers for Hunter Syndrome
NCT01330277 ·Status: TERMINATED
-
Biomarkers Related to Bone in Pediatric Gaucher Disease
NCT06116071 ·Status: RECRUITING
-
Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
NCT00344331 ·Status: RECRUITING
-
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
NCT06673290 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
NCT00975689 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
NCT07187193 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
NCT00157118 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Screening Study Evaluating Disease Status of Gaucher Type I Patients
NCT00795197 ·Status: WITHDRAWN
-
Heart and Muscle Metabolism in Barth Syndrome
NCT01625663 ·Status: COMPLETED
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
NCT01744782 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Studies of the Glycoproteinoses
NCT01891422 ·Status: COMPLETED
-
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)
NCT04125927 ·Status: COMPLETED ·Phase: PHASE3
-
DFT383 in Pediatric Participants With Nephropathic Cystinosis
NCT06910813 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
NCT02437396 ·Status: RECRUITING
-
Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
NCT01733615 ·Status: TERMINATED
-
Gaucherite - A Study to Stratify Gaucher Disease
NCT03240653 ·Status: RECRUITING
-
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes
NCT06111950 ·Status: RECRUITING ·Phase: NA
-
Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease
NCT02416661 ·Status: COMPLETED
-
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
NCT06065605 ·Status: UNKNOWN
-
Senicapoc and Dehydrated Stomatocytosis
NCT04372498 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Induced Pluripotent Stem Cells for Niemann Pick Disease
NCT03883750 ·Status: COMPLETED
-
MK-7075 (Miransertib) in Proteus Syndrome
NCT04316546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of STG-001 in Subjects With Stargardt Disease
NCT04489511 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients
NCT04246060 ·Status: ENROLLING_BY_INVITATION